Coherus Biosciences Inc

NASDAQ:CHRS   3:29:41 PM EDT
18.38
+0.01 (+0.05%)
Earnings Announcements

Coherus Biosciences Reports Third Quarter 2021 Results

Published: 11/08/2021 21:12 GMT
Coherus Biosciences Inc (CHRS) - Coherus Biosciences Reports Third Quarter 2021 Results.
Q3 Loss per Share $0.49.
Q3 Sales $83 Million.
Qtrly Adjusted Loss per Share $0.34.
Q3 Earnings per Share View $-0.22, Revenue View $91.3 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $82.94 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $78.94 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.